SC 13GCTNMCIK 0001855175

Contineum Therapeutics, Inc.

Name: SEC EDGAR filing 0002050709-26-000029
Creator: Contineum Therapeutics, Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G) filed October 28, 2026.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Open the filing on SEC.gov

New to the SC 13G? What it is and how to read one

Filing facts

Accession number: 0002050709-26-000029
Filer: Contineum Therapeutics, Inc.
Ticker: CTNM
CIK: 0001855175
Form type: SC 13G
Form description: 5%+ passive stake
Filed at: October 28, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 28, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1855175/000205070926000029/0002050709-26-000029-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Contineum Therapeutics, Inc. (0001855175) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0002050709-26-000029.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.